Changing Cancer Care with CAR-T
Apr 14, 2022, 01:00 PM
In episode 106, Christi Shaw, CEO of Kite, a Gilead Company, talks about how CAR T-cell therapies are impacting cancer care and the lessons she’s learned along her career path.
We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.
Please check your internet connection and refresh the page. You might also try disabling any ad blockers.
You can visit our support center if you're having problems.